发明授权
US07795273B2 Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors
失效
吡唑并[1,5-a]吡啶-3-羧酸，为EphB和VEGFR2激酶抑制剂
![Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors](/docs/US/2010-09-14/US07795273B2/abs.jpg.600x600.jpg)
- 专利标题： Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors
- 专利标题（中）： 吡唑并[1,5-a]吡啶-3-羧酸，为EphB和VEGFR2激酶抑制剂
-
申请号： US12096260申请日： 2006-12-06
-
公开(公告)号： US07795273B2公开(公告)日： 2010-09-14
- 发明人: Patricia Imbach , Philipp Holzer , Pascal Furet
- 申请人： Patricia Imbach , Philipp Holzer , Pascal Furet
- 申请人地址： CH Basel
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： CH Basel
- 优先权： GB0525065.9 20051208; GB0600931.0 20060117
- 国际申请： PCT/EP2006/011722 WO 20061206
- 国际公布： WO2007/065664 WO 20070614
- 主分类号： A01N43/42
- IPC分类号： A01N43/42 ; A61K31/44 ; C07D491/02 ; C07D498/02
![Pyrazolo[1,5-a]pyridine-3-carboxylic acids as EphB and VEGFR2 kinase inhibitors](/abs-image/US/2010/09/14/US07795273B2/abs.jpg.150x150.jpg)
摘要：
The invention relates to novel pyrazolo[1,5-a]pyridine-3-carboxylic acid compounds of the formula in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their use as medicaments and to medicaments comprising them.